State Street’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,309,753
| Closed | -$12.3M | – | 3938 |
|
|
2020
Q3 | $12.3M | Sell |
1,309,753
-128,524
| -9% | -$1.22M | ﹤0.01% | 2320 |
|
|
2020
Q2 | $11M | Sell |
1,438,277
-1,453,755
| -50% | -$11.1M | ﹤0.01% | 2368 |
|
|
2020
Q1 | $17.9M | Buy |
2,892,032
+177,933
| +7% | +$1.57M | ﹤0.01% | 1906 |
|
|
2019
Q4 | $33M | Buy |
2,714,099
+197,535
| +8% | +$2.16M | ﹤0.01% | 1802 |
|
|
2019
Q3 | $29.1M | Sell |
2,516,564
-216,706
| -8% | -$2.28M | ﹤0.01% | 1808 |
|
|
2019
Q2 | $27.3M | Sell |
2,733,270
-90,556
| -3% | -$977K | ﹤0.01% | 1896 |
|
|
2019
Q1 | $36.4M | Buy |
2,823,826
+239,180
| +9% | +$3.56M | ﹤0.01% | 1640 |
|
|
2018
Q4 | $39.3M | Sell |
2,584,646
-23,433
| -0.9% | -$446K | ﹤0.01% | 1511 |
|
|
2018
Q3 | $52.2M | Sell |
2,608,079
-97,803
| -4% | -$2.23M | ﹤0.01% | 1493 |
|
|
2018
Q2 | $52.8M | Buy |
2,705,882
+36,370
| +1% | +$805K | ﹤0.01% | 1445 |
|
|
2018
Q1 | $53.8M | Sell |
2,669,512
-293,372
| -10% | -$4.96M | ﹤0.01% | 1379 |
|
|
2017
Q4 | $39.3M | Buy |
2,962,884
+500,200
| +20% | +$7.54M | ﹤0.01% | 1592 |
|
|
2017
Q3 | $45.4M | Sell |
2,462,684
-327,248
| -12% | -$6.1M | ﹤0.01% | 1441 |
|
|
2017
Q2 | $51.3M | Buy |
2,789,932
+267,873
| +11% | +$5.31M | ﹤0.01% | 1339 |
|
|
2017
Q1 | $56.9M | Buy |
2,522,059
+1,082,366
| +75% | +$25.9M | 0.01% | 1250 |
|
|
2016
Q4 | $50.1M | Sell |
1,439,693
-379,814
| -21% | -$11.3M | ﹤0.01% | 1266 |
|
|
2016
Q3 | $44.6M | Sell |
1,819,507
-28,468
| -2% | -$711K | ﹤0.01% | 1270 |
|
|
2016
Q2 | $44.2M | Buy |
1,847,975
+225,840
| +14% | +$5.18M | ﹤0.01% | 1249 |
|
|
2016
Q1 | $38M | Sell |
1,622,135
-132,932
| -8% | -$3.16M | ﹤0.01% | 1302 |
|
|
2015
Q4 | $53M | Buy |
1,755,067
+747,839
| +74% | +$24.2M | 0.01% | 1156 |
|
|
2015
Q3 | $40M | Buy |
1,007,228
+164,964
| +20% | +$10.2M | ﹤0.01% | 1295 |
|
|
2015
Q2 | $58.2M | Buy |
842,264
+43,841
| +5% | +$2.76M | 0.01% | 1174 |
|
|
2015
Q1 | $43.6M | Buy |
798,423
+25,597
| +3% | +$1.22M | ﹤0.01% | 1318 |
|
|
2014
Q4 | $32.9M | Sell |
772,826
-222,589
| -22% | -$8.04M | ﹤0.01% | 1461 |
|
|
2014
Q3 | $31.8M | Sell |
995,415
-124,050
| -11% | -$2.65M | ﹤0.01% | 1417 |
|
|
2014
Q2 | $23.2M | Sell |
1,119,465
-149,725
| -12% | -$2.77M | ﹤0.01% | 1722 |
|
|
2014
Q1 | $24.6M | Buy |
1,269,190
+644,217
| +103% | +$13.7M | ﹤0.01% | 1623 |
|
|
2013
Q4 | $15.2M | Buy |
624,973
+66,937
| +12% | +$1.57M | ﹤0.01% | 1930 |
|
|
2013
Q3 | $12M | Buy |
558,036
+172,647
| +45% | +$4.08M | ﹤0.01% | 2022 |
|
|
2013
Q2 | $8.58M | Buy |
+385,389
| New | +$8.49M | ﹤0.01% | 2141 |
|
State Street's AMAG Position: Q4 2020 in Review
State Street sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 1,309,753 shares — an estimated $12.3M sold.
State Street first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $58.2M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- State Street reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- State Street sold 1,309,753 AMAG Pharmaceuticals shares in Q4 2020, an estimated $12.3M.
- State Street first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- State Street's AMAG Pharmaceuticals position peaked at $58.2M in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on State Street's 13F filing for Q4 2020, filed 16 Feb 2021.